2023
SAO RAFAEL HOSPITAL, BRAZIL POWERS SCREENING USING AI TECHNOLOGY
5 June 2023 – EyRIS is thrilled to announce our collaboration with Sao Rafael Hospital which is part of the renowned Rede D’Or São Luiz healthcare network in Brazil. This partnership underlines Rede D’Or São Luiz’s determination in improving patient care through state-of-the-art AI technology. By leveraging on SELENA+’s proven algorithms, Rede D’Or São Luiz aims to expand screening and…
SELENA+ IN ANOTHER COMMUNITY OUTREACH PROGRAM
2 June 2023 – EyRIS participated in another community outreach program, this time jointly organized by the Singapore Buddhist Youth Mission Temple and Diabetes Singapore, under the tagline “Healthiness is a Blessing”, aptly on Vesak Day. Worshippers were given the opportunity health check and experince EyRIS latest seamless workflow, which captures the fundus image and return the SELENA+ results of…
MEMORANDUM OF UNDERSTANDING EyRIS and Optometrist Warehouse signed MOU to collaborate on study focused on the effectiveness of AI in screening diabetic retinopathy in Australia
NOVA MSC BERHAD 01 June 2023 Type Announcement Subject MEMORANDUM OF UNDERSTANDING Description EyRIS and Optometrist Warehouse signed MOU to collaborate on study focused on the effectiveness of AI in screening diabetic retinopathy in Australia Please find attached Press Release in respect of the signing of a Memorandum of Understanding (“MOU”) between (i) Eyris Pte Ltd (“Eyris”), which is…
OTHERS Nova MSC Berhad (NOVAMSC or Company) – ACE Market Listing Requirements for at least 1 woman director on board
NOVA MSC BERHAD 01 June 2023 Type Announcement Subject OTHERS Description Nova MSC Berhad (NOVAMSC or Company) – ACE Market Listing Requirements for at least 1 woman director on board NOVAMSC wishes to inform that our Board of Directors (“Board”) as at the date of this announcement is an all-male board of directors, and the Company is in the…
EYRIS AND OPTOMETRIST WAREHOUSE JOIN FORCES TO ADVANCE HEALTHCARE WITH AI-DRIVEN DIABETIC RETINOPATHY SCREENING
1 June 2023 – EyRIS, a pioneering company in artificial intelligence (AI) healthcare solutions, and Optometrist Warehouse, part of the Chemist Warehouse Group in Australia, have signed a Memorandum of Understanding (MOU) to collaborate on a ground-breaking study focused on the effectiveness of AI in screening diabetic retinopathy. This collaboration marks a significant milestone in the field of healthcare, showcasing…
NOVA FEATURES LATEST HEALTHCARE INNOVATIONS AT APHM 2023
Jun 2023 – NOVA MSC Berhad, together with our partner Theta Edge Berhad had a successful 3-day event from 30 May – 1 June at the APHM (Association of Private Hospitals Malaysia) International Healthcare Conference & Exhibition 2023, Kuala Lumpur. Organised under the apt theme, “New Dynamics in Delivery of Healthcare” to address this ever changing milieu of healthcare delivery,…
SELENA+ RECEIVES REGULATORY APPROVAL FROM MINISTRY OF HEALTH & PREVENTION, UAE
May 2023 – We are thrilled to announce that SELENA+ has successfully attained regulatory approval from the Ministry of Health & Prevention, United Arab Emirates (UAE). market At nearly 19%, UAE has one of the world’s highest rates of diabetes. With diabetes comes complications such as diabetes retinopathy (DR) which left untreated can lead to blindness. It is well-documented that…
EYRIS SIGNS PARTNERSHIP WITH VUNO
May 2023 – EyRIS is excited to announce our partnership with VUNO which supplies VUNO Med-Fundus AI, a complimentary AI solution used for detection of 12 fundus abnormalities. This innovation promises to contribute to a holistic AI offering on the EyRIS platform. This strategic partnership between VUNO and EyRIS brings value to the eye screening community as it provides an…
Quarterly rpt on consolidated results for the financial period ended 31 Mar 2023
NOVA MSC BERHAD 31 May 2023 Financial Year End 31 Mar 2023 Quarter 4 Qtr Quarterly report for the financial period ended 31 Mar 2023 The figures have not been audited
Additional Listing Announcement /Subdivision of Shares
NOVA MSC BERHAD 19 May 2023 1. Details of Corporate Proposal Involve issuance of new type/class of securities ? No Types of corporate proposal Conversion of Preference Shares Details of corporate proposal Conversion of Irredeemable Convertible Preference Shares No. of shares issued under this corporate proposal 53,500 Issue price per share ($$) Malaysian Ringgit (MYR) 0.0400 Par Value($$) (if…
SELENA+ JOURNEY FEATURED PHYSICIAN SCIENTIST SUMMIT IN JORDAN
4 May 2023 – Aqaba Medical Sciences University (AMSU) and Jordan Medical Association (JMA) jointly organised the inaugural Physician Scientist Summit which serves as an important congregation of stakeholders in the scientific medical research landscape – providing collaborative opportunities, scientific tools and knowledge to Jordanian physicians at all levels. It is the country’s largest medical scientific gathering. EyRIS is proud…
PANAGA HEALTH CHOOSES VESALIUS
Apr 2023 – Panaga Health Centre (PHC), Brunei Darussalam opened in 1968 to provide quality medical and health services to the employees of Brunei Shell Petroleum (BSP) along with their dependents and also the public. Primarily, PHC is a primary health centre that operates emergency services together with ancillary departments such as laboratory, diagnostic imaging and occupational health. To improve…